DE69026506D1 - Biologisches präparat und seine verwendung - Google Patents

Biologisches präparat und seine verwendung

Info

Publication number
DE69026506D1
DE69026506D1 DE69026506T DE69026506T DE69026506D1 DE 69026506 D1 DE69026506 D1 DE 69026506D1 DE 69026506 T DE69026506 T DE 69026506T DE 69026506 T DE69026506 T DE 69026506T DE 69026506 D1 DE69026506 D1 DE 69026506D1
Authority
DE
Germany
Prior art keywords
biological preparation
antigenic
relates
material derived
treatment against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69026506T
Other languages
English (en)
Other versions
DE69026506T2 (de
Inventor
John Stanford
Graham Rook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Application granted granted Critical
Publication of DE69026506D1 publication Critical patent/DE69026506D1/de
Publication of DE69026506T2 publication Critical patent/DE69026506T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Thin Film Transistor (AREA)
  • Recrystallisation Techniques (AREA)
  • Steroid Compounds (AREA)
DE69026506T 1989-07-28 1990-07-27 Biologisches präparat und seine verwendung Expired - Fee Related DE69026506T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898917256A GB8917256D0 (en) 1989-07-28 1989-07-28 Biological preparation and its use
PCT/GB1990/001169 WO1991001751A1 (en) 1989-07-28 1990-07-27 Biological preparation and its use

Publications (2)

Publication Number Publication Date
DE69026506D1 true DE69026506D1 (de) 1996-05-15
DE69026506T2 DE69026506T2 (de) 1996-09-12

Family

ID=10660759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69026506T Expired - Fee Related DE69026506T2 (de) 1989-07-28 1990-07-27 Biologisches präparat und seine verwendung

Country Status (13)

Country Link
EP (1) EP0484438B1 (de)
JP (1) JPH05500803A (de)
AT (1) ATE136467T1 (de)
AU (1) AU644376B2 (de)
CA (1) CA2064029C (de)
DE (1) DE69026506T2 (de)
DK (1) DK0484438T3 (de)
ES (1) ES2088431T3 (de)
FI (1) FI920356A0 (de)
GB (1) GB8917256D0 (de)
NO (1) NO920331L (de)
WO (1) WO1991001751A1 (de)
ZA (1) ZA905927B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
AU660430B2 (en) * 1990-11-08 1995-06-29 Stanford Rook Limited Mycobacterium as adjuvant for antigens
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
US8110204B2 (en) * 2001-01-17 2012-02-07 Cadila Pharmaceuticals Ltd. Method of treating human-immunodeficiency virus (HIV) disease infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen

Also Published As

Publication number Publication date
EP0484438A1 (de) 1992-05-13
ES2088431T3 (es) 1996-08-16
WO1991001751A1 (en) 1991-02-21
EP0484438B1 (de) 1996-04-10
GB8917256D0 (en) 1989-09-13
NO920331D0 (no) 1992-01-24
CA2064029C (en) 1998-12-29
NO920331L (no) 1992-01-24
DK0484438T3 (da) 1996-06-10
JPH05500803A (ja) 1993-02-18
CA2064029A1 (en) 1991-01-29
AU6188390A (en) 1991-03-11
ZA905927B (en) 1991-05-29
FI920356A0 (fi) 1992-01-27
DE69026506T2 (de) 1996-09-12
ATE136467T1 (de) 1996-04-15
AU644376B2 (en) 1993-12-09

Similar Documents

Publication Publication Date Title
DE69116377D1 (de) Mycobacterium vaccae in der behandlung von uveitis
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE69026506D1 (de) Biologisches präparat und seine verwendung
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
DE3886254D1 (de) Apparat zur Behandlung von biologischen Proben und Behandlungsmethoden mit dem Apparat.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
AT380202B (de) Material zur herstellung von artikeln zur abstuetzung des kopfes oder von gliedmassen des menschen oder von tieren, sowie aus diesem material hergestellte artikel
DE69004037D1 (de) Apparat zur Wärmebehandlung von kontaminiertem, stückigem Material.
CA2186851A1 (en) Use of mycobacteria for the treatment of tumours
ATE151641T1 (de) Mycobacterium vaccae zur behandlung von langwierigen autoimmunerkrankungen
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
DK0427462T3 (da) Fremgangsmåde
DE3774931D1 (de) Einrichtung zur gesteuerten waermebehandlung von weichenteilen.
ATE75727T1 (de) Noremopamil, seine herstellung und verwendung.
JPS6471488A (en) Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.
ES1005800Y (es) Dispositivo manual mejorado reactivador de la circulacion cutanea por friccion
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
DE3770945D1 (de) Vorrichtung zur behandlung von luftschiffen.
RO77099A2 (ro) Compozitie medicamentoasa destinata tratamentului gastritelor,gastroduodenitelor si ulcerelor gastroduedenale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: STANFORD ROOK LTD., LONDON, GB

8339 Ceased/non-payment of the annual fee